	Awareness of magnetic resonance imaging for early detection of breast cancer: A cross-sectional study. J Int Med Res Almusined MM, Albeshan SM, Alshabibi AS, Almutairy AM, Almujali HA, Aloufi AS. PMID: 41299197 [PubMed - as supplied by publisher]
	Non-coding RNAs-regulated SLC7A11 modulates ferroptosis: a new strategy for cancer therapy. Funct Integr Genomics Niu X, Nie J, Zhang L, Chen F, Lin Z. PMID: 41299157 [PubMed - as supplied by publisher]
	Targeting ferroptosis by noncoding RNAs as a novel therapeutic strategy for hepatocellular carcinoma. Discov Oncol Mohammadi Y, Mahdiabadi MA, Ourang Z, Bahreini E, Abaszade-Cheragheali A. PMID: 41299136 [PubMed - as supplied by publisher]
	Natural products as therapeutic interventions for inflammation-mediated cancer. Discov Oncol Roy S, Shaw R, Pandey A, Trigun SK. PMID: 41299103 [PubMed - as supplied by publisher]
	NLRPs and tumor: research progress from molecular mechanisms to clinical applications. Oncogene Song L, Cao Y, Tao Y. PMID: 41299065 [PubMed - as supplied by publisher]
	Research progress in computer-aided diagnosis systems for lung cancer. NPJ Digit Med Ma K, Zheng M, Chen W, Qi Y, Rong H. PMID: 41299062 [PubMed - as supplied by publisher]
	Combination therapy overcomes secondary PARPi resistance in ATM-deficient prostate cancer. NPJ Precis Oncol Arce-Gallego S, Esquefa V, Domenech H, Salca A, Aguilar D, Casals T, Mir G, Simonetti S, Oliveira A, de Llobet L, Neeb A, Brandariz J, Anselmino N, Casanova-Salas I, Herranz N, Serra V, de Bono JS, Mateo J. PMID: 41299058 [PubMed - as supplied by publisher]
	A multimodal framework for comprehensive driver variant prediction in cancer. Commun Med (Lond) Yang H, Chen Y, Zhou T, Wang Y, Zhou Q, Xiao T, Zhang Q, Zhang J, Li D, Wang Z. PMID: 41299038 [PubMed - as supplied by publisher]
	KRAS-targeted therapies in colorectal cancer: a systematic analysis of mutations, inhibitors, and clinical trials. NPJ Precis Oncol Navarro-Jiménez M, González B, Mulet N, Hierro C, Alonso S. PMID: 41299036 [PubMed - as supplied by publisher]
	Testosterone replacement therapy following definitive treatment for prostate cancer: a scoping review of safety and efficacy. Int J Impot Res Gibson J, George M, Grice P, Mohee A, Stasinou T, Pearce I, Modgil V, Manchester Andrology Research Collaborative (MARC). PMID: 41299030 [PubMed - as supplied by publisher]
	Effectiveness of virtual reality-based exercise rehabilitation for enhancing functional outcomes and quality of life in adult cancer survivors: A systematic review of randomized controlled trials. J Cancer Surviv Eid M, Alkerdasy H, Hilmy A, Sameh A, Ashraf A. PMID: 41298970 [PubMed - as supplied by publisher]
	Prognostic impact of lymphadenectomy in patients with advanced ovarian clear cell carcinoma: an ancillary analysis of the JGOG3017-A4 study. Int J Clin Oncol Fujiwara S, Shimada M, Ito Y, Takei Y, Kuroda T, Nishino K, Chiyoda T, Terao Y, Sugiyama T, Okamoto A. PMID: 41298960 [PubMed - as supplied by publisher]
	Intraoperative complications during gastrectomy for gastric cancer - incidence, treatment, and effect on postoperative complications and survival in a population-based nationwide study. Langenbecks Arch Surg Junttila A, Helminen O, Helmiö M, Huhta H, Jalkanen A, Kallio R, Koivukangas V, Kokkola A, Laine S, Lietzen E, Louhimo J, Meriläinen S, Pohjanen VM, Rantanen T, Ristimäki A, Räsänen JV, Saarnio J, Sihvo E, Toikkanen V, Tyrväinen T, Valtola A, Kauppila JH, FINEGO group. PMID: 41298944 [PubMed - as supplied by publisher]
	Bladder cancer diagnostic and prognostic models from DNA methylation by multi algorithm machine learning. NPJ Precis Oncol Shen J, Li Z, Wang R, Ding G, Zhang Y. PMID: 41298892 [PubMed - as supplied by publisher]
	Integrative mendelian randomization and multi-omics analysis reveal a gut microbiota-metabolite-CXCL10 axis in breast cancer. AMB Express Qu J, Zhang F, Wang L, Zhang Y, Wang Y. PMID: 41298864 [PubMed - as supplied by publisher]
	Evaluating PI-RADS lesions and clinically significant prostate cancer in Black and Asian men: a PREVENT randomized clinical trial secondary analysis. Prostate Cancer Prostatic Dis Driscoll CB, Handa N, Huang MM, Murphy AB, Hu JC, Schaeffer EM. PMID: 41298852 [PubMed - as supplied by publisher]
	Identification of causal plasma proteins and targeted therapy for primary hepatic carcinoma via proteome-wide Mendelian randomization. Commun Biol Wang H, Hu K, Tang C, Li C, Dai J, Chen W, Ding Z, Liu F, Li Z. PMID: 41298802 [PubMed - as supplied by publisher]
	A autophagy related gene signature to predict the prognosis of pancreatic carcinoma and tumor immune microenvironment evaluation. Sci Rep Wang X, Wang X, Ying B. PMID: 41298756 [PubMed - in process]
	High risk HPV among HIV positive women with normal and abnormal cervical cytology in Bahir Dar, north west Ethiopia. Sci Rep Abate A, Azage M. PMID: 41298677 [PubMed - indexed for MEDLINE]
	Association between body mass index and efficacy of neoadjuvant targeted therapy in HER2-positive breast cancer in a Chinese multicenter cohort. Sci Rep Hong C, Yang P, Chen D, Lian W. PMID: 41298655 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 1879395

Page 1 of 93970



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy